Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsu Shinkai

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Clinical Pharmacology and Therapeutics|September 27, 2022
Effect of Trastuzumab Deruxtecan on QT/QTc Interval and Pharmacokinetics in HER2-Positive or HER2-Low Metastatic/Unresectable Breast CancerAkihiko Shimomura, Toshimi Takano, Shunji Takahashi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 2, 2008
A randomized, double-blind, phase IIa dose-finding study of Vandetanib (ZD6474) in Japanese patients with non-small cell lung cancerKatsuyuki Kiura, Kazuhiko Nakagawa, Tetsu Shinkai, et al.
Cancer Chemotherapy and Pharmacology|March 18, 2014
Factor associated with failure to administer subsequent treatment after progression in the first-line chemotherapy in EGFR-mutant non-small cell lung cancer: Okayama Lung Cancer Study Group experienceYuka Kato, Katsuyuki Hotta, Nagio Takigawa, et al.
BMC Cancer|May 14, 2016
Feasibility study of first-line chemotherapy using Pemetrexed and Bevacizumab for advanced or recurrent nonsquamous non-small cell lung cancer in elderly patients: TORG1015Toshiyuki Kozuki, Naoyuki Nogami, Hiromoto Kitajima, et al.
Lung Cancer (Amsterdam, Netherlands)|June 30, 2006
A phase I and pharmacological study of amrubicin and topotecan in patients of small-cell lung cancer with relapsed or extensive-disease small-cell lung cancerTakuo Shibayama, Katsuyuki Hotta, Nagio Takigawa, et al.
Lung Cancer (Amsterdam, Netherlands)|February 16, 2010
Phase I/II trial of gemcitabine plus oral TS-1 in elderly patients with advanced non-small cell lung cancer: Thoracic oncology research group study 0502Takashi Seto, Takeharu Yamanaka, Izumi Wasada, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 12, 2014
[Awareness about medical expenses and certifications of eligibility for limited health insurance payments for chemotherapy among clinicians at the Ehime Cancer Care Network Priority Hospitals (Ehime Cancer Kyoten Hospitals)]Yoshihiro Yakushijin, Junko Morita, Takuya Yano, et al.
Lung Cancer (Amsterdam, Netherlands)|February 22, 2011
A phase II study of amrubicin and topotecan combination therapy in patients with relapsed or extensive-disease small-cell lung cancer: Okayama Lung Cancer Study Group Trial 0401Naoyuki Nogami, Katsuyuki Hotta, Shoichi Kuyama, et al.
Cancer Chemotherapy and Pharmacology|May 6, 2004
Clinical and pharmacokinetic study of docetaxel in elderly non-small-cell lung cancer patientsNagio Takigawa, Yoshihiko Segawa, Daizo Kishino, et al.
Anticancer Research|August 6, 2005
Phase I study of irinotecan and amrubicin in patients with advanced non-small-cell lung cancerKatsuyuki Hotta, Nagio Takigawa, Katsuyuki Kiura, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Clinical Pharmacology and Therapeutics|September 27, 2022
Effect of Trastuzumab Deruxtecan on QT/QTc Interval and Pharmacokinetics in HER2-Positive or HER2-Low Metastatic/Unresectable Breast CancerAkihiko Shimomura, Toshimi Takano, Shunji Takahashi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 2, 2008
A randomized, double-blind, phase IIa dose-finding study of Vandetanib (ZD6474) in Japanese patients with non-small cell lung cancerKatsuyuki Kiura, Kazuhiko Nakagawa, Tetsu Shinkai, et al.
Cancer Chemotherapy and Pharmacology|March 18, 2014
Factor associated with failure to administer subsequent treatment after progression in the first-line chemotherapy in EGFR-mutant non-small cell lung cancer: Okayama Lung Cancer Study Group experienceYuka Kato, Katsuyuki Hotta, Nagio Takigawa, et al.
BMC Cancer|May 14, 2016
Feasibility study of first-line chemotherapy using Pemetrexed and Bevacizumab for advanced or recurrent nonsquamous non-small cell lung cancer in elderly patients: TORG1015Toshiyuki Kozuki, Naoyuki Nogami, Hiromoto Kitajima, et al.
Lung Cancer (Amsterdam, Netherlands)|June 30, 2006
A phase I and pharmacological study of amrubicin and topotecan in patients of small-cell lung cancer with relapsed or extensive-disease small-cell lung cancerTakuo Shibayama, Katsuyuki Hotta, Nagio Takigawa, et al.
Lung Cancer (Amsterdam, Netherlands)|February 16, 2010
Phase I/II trial of gemcitabine plus oral TS-1 in elderly patients with advanced non-small cell lung cancer: Thoracic oncology research group study 0502Takashi Seto, Takeharu Yamanaka, Izumi Wasada, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 12, 2014
[Awareness about medical expenses and certifications of eligibility for limited health insurance payments for chemotherapy among clinicians at the Ehime Cancer Care Network Priority Hospitals (Ehime Cancer Kyoten Hospitals)]Yoshihiro Yakushijin, Junko Morita, Takuya Yano, et al.
Lung Cancer (Amsterdam, Netherlands)|February 22, 2011
A phase II study of amrubicin and topotecan combination therapy in patients with relapsed or extensive-disease small-cell lung cancer: Okayama Lung Cancer Study Group Trial 0401Naoyuki Nogami, Katsuyuki Hotta, Shoichi Kuyama, et al.
Cancer Chemotherapy and Pharmacology|May 6, 2004
Clinical and pharmacokinetic study of docetaxel in elderly non-small-cell lung cancer patientsNagio Takigawa, Yoshihiko Segawa, Daizo Kishino, et al.
Anticancer Research|August 6, 2005
Phase I study of irinotecan and amrubicin in patients with advanced non-small-cell lung cancerKatsuyuki Hotta, Nagio Takigawa, Katsuyuki Kiura, et al.
Pageof 5